| Title | Date | PubMed ID |
|---|
| The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis. | 2015 May | 25549795 |
| Expression and activity levels of matrix metalloproteinase-7 and in situ localization of caseinolytic activity in colorectal cancer. | 2014 Sep | 24930385 |
| Pericellular proteolysis by matrix metalloproteinase-7 is differentially modulated by cholesterol sulfate, sulfatide, and cardiolipin. | 2014 Aug | 24903600 |
| Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior. | 2014 Jun | 24833109 |
| Matrilysin (MMP-7) catalytic activity regulates β-catenin localization and signaling activation in lung epithelial cells. | 2014 Apr | 24624896 |
| Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients. | 2014 Mar | 24469951 |
| Effects of heparin and cholesterol sulfate on the activity and stability of human matrix metalloproteinase 7. | 2014 | 25036482 |
| Design, synthesis and biological evaluation of 3,9-diazatetraasteranes as novel matrilysin inhibitors. | 2013 Nov | 23834648 |
| The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells. | 2012 Jan 27 | 22227189 |
| Tyr219 of human matrix metalloproteinase 7 is not critical for catalytic activity, but is involved in the broad pH-dependence of the activity. | 2011 Aug | 21593056 |